|
|
|
|
Home | Search | Advance Search | Browse | Online Submission | Documentation & FAQ | Team | Contact us |
|
| PolysacDB ID | 1007 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium tuberculosis (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues, and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages |
| Antigenic Nature | Heat killed Mycobacterium tuberculosis |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 5c11 |
| Antibody Type Class | IgM |
| Assay System | Indirect immunofluorescence, ELISA, western blotting |
| Cross Reactivity | This antibody cross-reacted with large number of mycobacterial species. |
| Proposed Epitope | Arabinose moiety of Lipoarabinomannan |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody has been used in the detection of mycobacteria in clinical samples |
| Curator ID | AA + AS |
| Date of Curation | 02-01-2010 |
| References | PMC229406 |
| PolysacDB ID | 1008 |
| Carbohydrate Name | Mycolyl-arabinogalactan-peptidoglycan complex (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium tuberculosis (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycolyl-arabinogalactan-peptidoglycan complex is the fraction of the mycobacterial cell wall left after removing all soluble carbohydrates, proteins and lipids |
| BCSDB Structure | N/A |
| Proposed Function | Contains lipoarabinomannan as well as arabinose that are important virulence factors |
| Antigenic Nature | Heat killed Mycobacterium tuberculosis |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mabs 4f11 |
| Antibody Type Class | IgM |
| Assay System | Indirect immunofluorescence, ELISA, western blotting |
| Cross Reactivity | This antibody cross-reacted with large number of mycobacterial species. |
| Proposed Epitope | Arabinose moiety of Lipoarabinomannan |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody has been used in the detection of mycobacteria in clinical samples |
| Curator ID | AA + AS |
| Date of Curation | 02-01-2010 |
| References | PMC229406 |
| PolysacDB ID | 1009 |
| Carbohydrate Name | Unknown carbohydrate (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium tuberculosis (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | N/A |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Heat killed Mycobacterium tuberculosis |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 9d8 |
| Antibody Type Class | IgG3 |
| Assay System | Indirect immunofluorescence, ELISA, western blotting |
| Cross Reactivity | This antibody cross-reacted with M.gordonae, M. gastri, and M. Kansasii |
| Proposed Epitope | N\A |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody has been used in the detection of mycobacteria in clinical samples |
| Curator ID | AA + AS |
| Date of Curation | 03-01-2010 |
| References | PMC229406 |
| PolysacDB ID | 1010 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium tuberculosis (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues, and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | Reported to suppress T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages. Other reported effects include inhibition of protein kinases, inhibition of the synthesis of mRNA encoding IL-2, IL-5, and granulocyte-macrophage colony stimulating factor (GM-CSF) in human T cells and activation of the complement cascade |
| Antigenic Nature | Heat killed Mycobacterium tuberculosis |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | SMITB14 |
| Antibody Type Class | IgG1 |
| Assay System | N\A |
| Cross Reactivity | SMITB14 bound to whole M. tuberculosis bacteria (H37Rv and Harlingen strains) as well as to the attenuated BCG, but not to other species such as Escherichia coli strains of various O serotypes, Streptococcus pneumoniae isolates, strains of Salmonella, Yersinia enterocolitica and Y. pseudotuberculosis and Nocardia sp. |
| Proposed Epitope | Arabinomannan portion of the antigen |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody might be involved in blocking of mycobacterial invasion. SMITB14 may prevent the uptake of M. tuberculosis through receptor(s) that facilitate bacterial survival and growth. |
| Curator ID | AA + AS |
| Date of Curation | 03-01-2010 |
| References | PMC1809178 |
| PolysacDB ID | 1011 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium tuberculosis (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues, and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | Reported to suppress T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages. Other reported effects include inhibition of protein kinases, inhibition of the synthesis of mRNA encoding IL-2, IL-5, and granulocyte-macrophage colony stimulating factor (GM-CSF) in human T cells and activation of the complement cascade |
| Antigenic Nature | Heat killed Mycobacterium tuberculosis |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab lam701 |
| Antibody Type Class | IgG3 |
| Assay System | Sandwich ELISA |
| Cross Reactivity | This antibody cross-reacted with cross-reacted to a large number of mycobacterial species such as M. tuberculosis, M. bovis, M leprae, M. phlei and M. avium |
| Proposed Epitope | N\A |
| IEDB Epitope | N/A |
| Proposed Utility | These antibodies could be used to detect mycobacterial antigens in sputum |
| Curator ID | AA + AS |
| Date of Curation | 03-01-2010 |
| References | 2127645 |
| PolysacDB ID | 1032 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages |
| Antigenic Nature | Whole killed mycobacteria leprae cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab lam038 |
| Antibody Type Class | IgM |
| Assay System | Sandwich ELISA |
| Cross Reactivity | This antibody cross-reacted with cross-reacted to a large number of mycobacterial species such as M. tuberculosis, M. bovis, M leprae, M. phlei and M. avium |
| Proposed Epitope | N\A |
| IEDB Epitope | N/A |
| Proposed Utility | These antibodies could be used to detect mycobacterial antigens in sputum |
| Curator ID | AA + AS |
| Date of Curation | 09-01-2010 |
| References | 2127645 |
| PolysacDB ID | 1033 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages |
| Antigenic Nature | Whole killed mycobacteria leprae cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab lam204 |
| Antibody Type Class | IgM |
| Assay System | Sandwich ELISA |
| Cross Reactivity | This antibody cross-reacted with cross-reacted to a large number of mycobacterial species such as M. tuberculosis, M. bovis, M leprae, M. phlei and M. avium |
| Proposed Epitope | N\A |
| IEDB Epitope | N/A |
| Proposed Utility | These antibodies could be used to detect mycobacterial antigens in sputum |
| Curator ID | AA + AS |
| Date of Curation | 09-01-2010 |
| References | 2127645 |
| PolysacDB ID | 1035 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages |
| Antigenic Nature | Whole killed mycobacteria leprae cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab lam603 |
| Antibody Type Class | IgM |
| Assay System | Sandwich ELISA |
| Cross Reactivity | This antibody cross-reacted with cross-reacted to a large number of mycobacterial species such as M. tuberculosis, M. bovis, M leprae, M. phlei and M. avium |
| Proposed Epitope | N\A |
| IEDB Epitope | N/A |
| Proposed Utility | These antibodies could be used to detect mycobacterial antigens in sputum |
| Curator ID | AA + AS |
| Date of Curation | 09-01-2010 |
| References | 2127645 |
| PolysacDB ID | 1036 |
| Carbohydrate Name | Lipoarabinomannan (Drugpedia) |
| Carbohydrate Class | Glycolipid |
| Microbe Name | Mycobacterium leprae (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Mycobacterial lipoarabinomannan is a phosphatidylinositol anchored lipoglycan that consists of an α1-->6 linked backbone, substituted to varying degrees at position 2 with single α-Man residues and directly attached to position 6 of the myo-inositol of a phosphatidylinositol (PI) anchor |
| BCSDB Structure | 127448 |
| Proposed Function | T cell proliferation and to interfere with gamma interferon-mediated activation of macrophages |
| Antigenic Nature | Whole killed mycobacteria leprae cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab Cs-35 |
| Antibody Type Class | IgM |
| Assay System | Indirect and Competitive ELISA |
| Cross Reactivity | This antibody cross-reacted to M. tuberculosis and other Mycobacterium speices. |
| Proposed Epitope | β-D-Araf- (1-->2)-α-D-Araf-(1-->5)-α- D-Araf-(1-->5)-α-D-Araf within the branched hexa-Araf motif of mycobacterial arabinans |
| IEDB Epitope | 76797 |
| Proposed Utility | These antibodies could be used for screening of cell-wall mutants of mycobacteria lacking AG and AraLAM motifs and the recognition of biosynthetic intermediates of cell-wall polysaccharides unique to mycobacteria. |
| Curator ID | AA + AS |
| Date of Curation | 10-01-2010 |
| References | 12368438 |
| PolysacDB ID | 1038 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Rhizobium leguminosarum (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | LPS is composed of three parts: (1) lipid A, (2) core polysaccharide, and (3) O antigen. The lipid A region contains two glucosamine sugar derivatives, each with three fatty acids and phosphate or pyrophosphate attached. The core polysaccharide has KDO and attached to lipid A. The side chain O is small polysaccharide chain extending outward from the core, it has several peculiar sugars and varies in composition between bacterial strains. |
| BCSDB Structure | 1686 |
| Proposed Function | LPS is most unusual constituents of outer membrane. It plays important role in host defence avoidance. LPS contributes to the negative charge of the bacterial surface. Lipid A is often toxic and act as endotoxin |
| Antigenic Nature | Mixture of suspension of cell envelop. |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 3 |
| Antibody Type Class | N\A |
| Assay System | Western blotting, spot imunoassays, agglutination tests |
| Cross Reactivity | This antibody was cross-reactive with different strains of R.leguminosarum like R.biovars viciae, trifolli and phaseoli. |
| Proposed Epitope | N/A |
| IEDB Epitope | N/A |
| Proposed Utility | N\A |
| Curator ID | AA + AS |
| Date of Curation | 10-01-2010 |
| References | PMC209711 |
| PolysacDB ID | 1040 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Chlamydia spp. (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | LPS is composed of three parts: (1) lipid A, (2) core polysaccharide, and (3) O antigen. The lipid A region contains two glucosamine sugar derivatives, each with three fatty acids and phosphate or pyrophosphate attached. The core polysaccharide has KDO and attached to lipid A. The side chain O is small polysaccharide chain extending outward from the core, it has several peculiar sugars and varies in composition between bacterial strains. |
| BCSDB Structure | 116693 |
| Proposed Function | LPS is most unusual constituents of outer membrane. It plays important role in host defence avoidance. LPS contributes to the negative charge of the bacterial surface. Lipid A is often toxic and act as endotoxin |
| Antigenic Nature | Formalin killed L2 EBs |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab L21-6 |
| Antibody Type Class | IgG3 |
| Assay System | Immunobloting |
| Cross Reactivity | This antibody was cross-reactive with Re LPS of S.typhimurium. |
| Proposed Epitope | N/A |
| IEDB Epitope | N/A |
| Proposed Utility | Monoclonal antibody L21-6 recognizes chlamydal genus specific epitope. |
| Curator ID | AA + AS |
| Date of Curation | 12-01-2010 |
| References | PMC263518 |
| PolysacDB ID | 1041 |
| Carbohydrate Name | Phosphocholine (Drugpedia) |
| Carbohydrate Class | Capsular polysaccharide |
| Microbe Name | Pneumococcal strain WU(12) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Phosphocholine (PC) is an intermediate in the synthesis of phosphatidylcholine in tissues. Phosphocholine is made in a reaction, catalyzed by choline kinase, that converts ATP + Choline into Phosphocholine and ADP |
| BCSDB Structure | N/A |
| Proposed Function | Phosphocholine is determinant of lipotechoic acids of Gram positive bacteria |
| Antigenic Nature | Cell extract and heat killed Pneumococcal strain EF3296. |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | SR4W1 |
| Antibody Type Class | IgG2a |
| Assay System | Blood bactericidal assay, hemolytic activity |
| Cross Reactivity | N/A |
| Proposed Epitope | Phosphocholine |
| IEDB Epitope | N/A |
| Proposed Utility | Monoclonal antibody SR4W1 can protect mice against Pneumococcal infections. |
| Curator ID | AA + AS |
| Date of Curation | 12-01-2010 |
| References | PMC313299 |
| PolysacDB ID | 1042 |
| Carbohydrate Name | Glucan (Drugpedia) |
| Carbohydrate Class | Capsular polysaccharide |
| Microbe Name | Neurospora crassa (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | Glucans are a heterogeneous group of glucose polymers, consisting of a backbone of β(1-->3)-linked β-D-glucopyranosyl units with β(1-->6)-linked side chains of varying distribution and length |
| BCSDB Structure | N/A |
| Proposed Function | Activates leukocytes, stimulating their phagocytic, cytotoxic, and antimicrobial activities, including the production of reactive oxygen and nitrogen intermediates |
| Antigenic Nature | Homogenous suspension of hyphal walls. |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | S4D1 |
| Antibody Type Class | IgM |
| Assay System | ELISA, immunofluorescence |
| Cross Reactivity | This antibody was cross-reactive with A.nidulans, Schiz.commune. |
| Proposed Epitope | 1,3-α-glucan |
| IEDB Epitope | N/A |
| Proposed Utility | Screening of fungi for presence of 1,3-α-glucan in hyphae cell wall. |
| Curator ID | AA + AS |
| Date of Curation | 13-01-2010 |
| References | 9245814 |
| PolysacDB ID | 1045 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Salmonella typhimurium SR-11 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | LPS is composed of three parts: (1) lipid A, (2) core polysaccharide, and (3) O antigen. The lipid A region contains two glucosamine sugar derivatives, each with three fatty acids and phosphate or pyrophosphate attached. The core polysaccharide has KDO and attached to lipid A. The side chain O is small polysaccharide chain extending outward from the core, it has several peculiar sugars and varies in composition between bacterial strains. |
| BCSDB Structure | N/A |
| Proposed Function | LPS is most unusual constituents of outer membrane. It plays important role in host defence avoidance. LPS contributes to the negative charge of the bacterial surface. Lipid A is often toxic and act as endotoxin |
| Antigenic Nature | Live S.typhimurium SR cells. |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | ST-1 |
| Antibody Type Class | IgM |
| Assay System | ELISA Hemaggluttination assay |
| Cross Reactivity | This antibody was cross-reactive with Salmonella typhimurium LT-2, Salmonella typhimurium derby. |
| Proposed Epitope | O-polysaccharide |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody can be used in serological assays to detect the desired antigen. |
| Curator ID | AA + AS |
| Date of Curation | 13-01-2010 |
| References | 6203984 |
| PolysacDB ID | 1046 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Salmonella typhimurium SR-11 (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | LPS is composed of three parts: (1) lipid A, (2) core polysaccharide, and (3) O antigen. The lipid A region contains two glucosamine sugar derivatives, each with three fatty acids and phosphate or pyrophosphate attached. The core polysaccharide has KDO and attached to lipid A. The side chain O is small polysaccharide chain extending outward from the core, it has several peculiar sugars and varies in composition between bacterial strains. |
| BCSDB Structure | N/A |
| Proposed Function | LPS is most unusual constituents of outer membrane. It plays important role in host defence avoidance. LPS contributes to the negative charge of the bacterial surface. Lipid A is often toxic and act as endotoxin |
| Antigenic Nature | Live S.typhimurium SR cells. |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Polysera |
| Antibody Type Class | IgG |
| Assay System | ELISA Hemaggluttination assay |
| Cross Reactivity | This antibody was cross-reactive with Salmonella typhimurium LT-2, Salmonella typhimurium derby. Salmonella typhimurium dublin, Salmonella enteritidis and Salmonella paratyphi A. |
| Proposed Epitope | O-polysaccharide |
| IEDB Epitope | N/A |
| Proposed Utility | This antibody can be used in serological assays to detect the desired antigen. |
| Curator ID | AA + AS |
| Date of Curation | 14-01-2010 |
| References | 6203984 |
| PolysacDB ID | 1047 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 7 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody was specific to E. coli J5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 14-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1048 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 10 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody was specific to E. coli J5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 15-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1049 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 2 |
| Antibody Type Class | IgG1 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 15-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1050 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 4 |
| Antibody Type Class | IgG2a |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1051 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 5 |
| Antibody Type Class | IgG1 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1052 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 3 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1053 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 11 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1054 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 8 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1055 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 9 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
| PolysacDB ID | 1056 |
| Carbohydrate Name | Lipopolysaccharide (Drugpedia) |
| Carbohydrate Class | Lipopolysaccharide |
| Microbe Name | Escherichia coli strain J5 (chemotype Rc) (NCBI Taxonomy) (Drugpedia) |
| Basic Structure | The core oligosaccharide part of the LPS consists of the following residues : α-D-Glcp(1-->2)α-D-Glcp(1-->2)α-D-Glcp [branched to α-D-GlcpNAc(1-->3)] (1-->3)α-L-D-man-Hepp [branched to α-D-GlcpNAc(1-->7)α-L-D-man-Hepp(1-->7)] and [branched to a phosphate group] (1-->3)α-L-D-man-Hepp [branched to α-Kdop(2-->4)α-Kdop(2-->4)α-Kdop(2-6)Subst] and [branched to a phosphate group](1-->5) |
| BCSDB Structure | N/A |
| Proposed Function | N/A |
| Antigenic Nature | Whole cells |
| Carrier Name | Nil |
| Conjugate Method | Nil |
| Antibodies | Mab 13 |
| Antibody Type Class | IgG3 |
| Assay System | ELISA, Limulus assay, invivo protection assay |
| Cross Reactivity | This antibody ross-reacted with Salmonella minnesota strain R5 |
| Proposed Epitope | Terminal glucose residues |
| IEDB Epitope | N/A |
| Proposed Utility | N/A |
| Curator ID | AA + AS |
| Date of Curation | 16-01-2010 |
| References | 2455054 |
|
Bioinformatics Centre, Institute of Microbial Technology, Sec - 39A, Chandigarh, India - 160036 |